134 research outputs found

    Distributional chaotic generalized shifts

    Full text link
    Suppose XX is a finite discrete space with at least two elements, Γ\Gamma is a nonempty countable set, and consider self--map φ:ΓΓ\varphi:\Gamma\to\Gamma. We prove that the generalized shift σφ:XΓXΓ\sigma_\varphi:X^\Gamma\to X^\Gamma with σφ((xα)αΓ)=(xφ(α))αΓ\sigma_\varphi((x_\alpha)_{\alpha\in\Gamma})=(x_{\varphi(\alpha)})_{\alpha\in\Gamma} (for (xα)αΓXΓ(x_\alpha)_{\alpha\in\Gamma}\in X^\Gamma) is: \bullet distributional chaotic (uniform, type 1, type 2) if and only if φ:ΓΓ\varphi:\Gamma\to\Gamma has at least a non-quasi-periodic point, \bullet dense distributional chaotic if and only if φ:ΓΓ\varphi:\Gamma\to\Gamma does not have any periodic point, \bullet transitive distributional chaotic if and only if φ:ΓΓ\varphi:\Gamma\to\Gamma is one--to--one without any periodic point. We complete the text by counterexamples.Comment: 13 page

    Use of remote sensing for hydrological parameterisation of Alpine catchments

    No full text
    International audiencePhysically-based water balance models require a realistic parameterisation of land surface characteristics of a catchment. Alpine areas are very complex with strong topographically-induced gradients of environmental conditions, which makes the hydrological parameterisation of Alpine catchments difficult. Within a few kilometres the water balance of a region (mountain peak or valley) can differ completely. Hence, remote sensing is invaluable for retrieving hydrologically relevant land surface parameters. The assimilation of the retrieved information into the water balance model PROMET is demonstrated for the Toce basin in Piemonte/Northern Italy. In addition to land use, albedos and leaf area indices were derived from LANDSAT-TM imagery. Runoff, modelled by a water balance approach, agreed well with observations without calibration of the hydrological model. Keywords: PROMET, fuzzy logic based land use classification, albedo, leaf area inde

    Development of the 500 kW and 1 MW ORC turbine flow parts

    No full text
    There paper presents two types of developed ORC turbines. The silica oil (MDM) is used as the working media. Proposed turbines are developed for electric power in 500 kW and 1 MW. For the designing of that turbines there were only one geometric constraint: the minimum height of the blade – 20 mm. The final 3D calculations of all turbine stages are provided with accounting the real properties of working media. Gasdynamic efficiency of the developed turbine flow parts is adequate for the such type of power machines.Рассмотрены несколько вариантов проточных частей осевых турбин мощностью 500 кВт и 1 МВт для когенерационной установки, использующей в качестве рабочего тела силиконовое масло (MDM). Единственным геометрическим ограничением для проектирования этих турбин было минимальная высота лопатки – 20 мм. Окончательные трехмерные расчеты всех ступеней турбины проведены с учетом реальных свойств рабочего тела на основе модифицированного уравнения состояния Бенедикта-Вебба-Рубина. Газодинамическая эффективность разработанных проточных частей турбин удовлетворяет требованиям, предъявляемым к энергетическим машинам подобного рода.Розглянуто декілька варіантів проточних частин осьових турбін потужністю 50 кВт та 1 МВт для когенераційної установки, що використовує як робоче тіло силіконове масло (MDM). Єдиним геометричним обмеженням для проектування цих турбін було мінімальна висота лопатки – 20 мм. Остаточні тривимірні розрахунки всіх ступенів турбіни проведено з урахуванням реальних властивостей робочого тіла на основі модифікованого рівняння стану Бенедикта-Вебба-Рубіна. Газодинамічна ефективність розроблених проточних частин турбін задовольняє вимоги, що ставляться до енергетичних машин подібного роду

    The Interactions Between Rapeseed Lipoxygenase and Native Polyphenolic Compounds in a Model System

    Get PDF
    The focus of the present research was to study inhibition of lipoxygenase activity by rapeseed native polyphenols and the interactions between those compounds and the enzyme. The enzyme and polyphenolic compounds (polyphenols, phenolic acids) were extracted from rapeseed (Brassica napus) varieties Aviso and PR45DO3. The total phenolic compounds concentration in tested rapeseed was 1,485–1,691 mg/100 g d.m. (dry matter) and the free phenolic acids content in both rapeseed varieties was about 76 μg/100 g d.m. The isolated proteins showed lipoxygenase activity. Prooxidant properties of phenolic compounds in the presence of lipoxygenase and linoleic acid were observed rather in the case of extracts containing a relatively high concentration of miscellaneous polyphenols. Antioxidant properties were recorded in the case of phenolic acid extracts which contain only 1.4–1.9% of phenolics present in raw phenolic extracts. We propose that the prooxidant effect of phenolic compounds comes from quinone and oxidized polyphenols formation. The observed antioxidant activity of phenolic acid extracts is probably due to their ability to scavenge free radicals formed from linoleic acid. However, reduction of lipoxygenase ferric to ferrous ions, which prevent the activation of the enzyme and inhibited its activity, was also observed

    Cardiovascular imaging following perioperative myocardial infarction/injury

    Get PDF
    Patients developing perioperative myocardial infarction/injury (PMI) have a high mortality. PMI work-up and therapy remain poorly defined. This prospective multicenter study included high-risk patients undergoing major non-cardiac surgery within a systematic PMI screening and clinical response program. The frequency of cardiovascular imaging during PMI work-up and its yield for possible type 1 myocardial infarction (T1MI) was assessed. Automated PMI detection triggered evaluation by the treating physician/cardiologist, who determined selection/timing of cardiovascular imaging. T1M1 was considered with the presence of a new wall motion abnormality within 30 days in transthoracic echocardiography (TTE), a new scar or ischemia within 90 days in myocardial perfusion imaging (MPI), and Ambrose-Type II or complex lesions within 7 days of PMI in coronary angiography (CA). In patients with PMI, 21% (268/1269) underwent at least one cardiac imaging modality. TTE was used in 13% (163/1269), MPI in 3% (37/1269), and CA in 5% (68/1269). Cardiology consultation was associated with higher use of cardiovascular imaging (27% versus 13%). Signs indicative of T1MI were found in 8% of TTE, 46% of MPI, and 63% of CA. Most patients with PMI did not undergo any cardiovascular imaging within their PMI work-up. If performed, MPI and CA showed high yield for signs indicative of T1MI.Trial registration: https://clinicaltrials.gov/ct2/show/NCT02573532

    Viral Resistance in Hepatitis B: Prevalence and Management

    Get PDF
    Hepatitis B is a DNA virus affecting hundreds of millions of individuals worldwide. As the clinical sequelae of cirrhosis and hepatocellular cancer are increasingly recognized to be related to viral levels, the impetus increases to offer treatment to those previously not treated. With the development of more robust antivirals with reasonable safety profiles, long-term treatment is becoming more common. The oral nucleos(t)ide analogs have become the preferred first-line therapies for most genotypes of hepatitis B. Five are now available, all with different potencies and resistance profiles. Long-term data spanning several years are now available for most compounds in this arena. This article focuses on the common natural variants and those secondary to nucleos(t)ide therapy, as well as diagnostic methods to detect resistance

    The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

    Get PDF
    Objective Ovarian cancers comprise several histologically distinct tumour groups with widely different prognosis. We aimed to describe the worldwide distribution of ovarian cancer histology and to understand what role this may play in international variation in survival. Methods The CONCORD programme is the largest population-based study of global trends in cancer survival. Data on 681,759 women diagnosed during 1995â\u80\u932009 with cancer of the ovary, fallopian tube, peritoneum and retroperitonum in 51 countries were included. We categorised ovarian tumours into six histological groups, and explored the worldwide distribution of histology. Results During 2005â\u80\u932009, type II epithelial tumours were the most common. The proportion was much higher in Oceania (73.1%), North America (73.0%) and Europe (72.6%) than in Central and South America (65.7%) and Asia (56.1%). By contrast, type I epithelial tumours were more common in Asia (32.5%), compared with only 19.4% in North America. From 1995 to 2009, the proportion of type II epithelial tumours increased from 68.6% to 71.1%, while the proportion of type I epithelial tumours fell from 23.8% to 21.2%. The proportions of germ cell tumours, sex cord-stromal tumours, other specific non-epithelial tumours and tumours of non-specific morphology all remained stable over time. Conclusions The distribution of ovarian cancer histology varies widely worldwide. Type I epithelial, germ cell and sex cord-stromal tumours are generally associated with higher survival than type II tumours, so the proportion of these tumours may influence survival estimates for all ovarian cancers combined. The distribution of histological groups should be considered when comparing survival between countries and regions

    Lancet

    Get PDF
    BACKGROUND: In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014. METHODS: CONCORD-3 includes individual records for 37.5 million patients diagnosed with cancer during the 15-year period 2000-14. Data were provided by 322 population-based cancer registries in 71 countries and territories, 47 of which provided data with 100% population coverage. The study includes 18 cancers or groups of cancers: oesophagus, stomach, colon, rectum, liver, pancreas, lung, breast (women), cervix, ovary, prostate, and melanoma of the skin in adults, and brain tumours, leukaemias, and lymphomas in both adults and children. Standardised quality control procedures were applied; errors were rectified by the registry concerned. We estimated 5-year net survival. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden. For many cancers, Denmark is closing the survival gap with the other Nordic countries. Survival trends are generally increasing, even for some of the more lethal cancers: in some countries, survival has increased by up to 5% for cancers of the liver, pancreas, and lung. For women diagnosed during 2010-14, 5-year survival for breast cancer is now 89.5% in Australia and 90.2% in the USA, but international differences remain very wide, with levels as low as 66.1% in India. For gastrointestinal cancers, the highest levels of 5-year survival are seen in southeast Asia: in South Korea for cancers of the stomach (68.9%), colon (71.8%), and rectum (71.1%); in Japan for oesophageal cancer (36.0%); and in Taiwan for liver cancer (27.9%). By contrast, in the same world region, survival is generally lower than elsewhere for melanoma of the skin (59.9% in South Korea, 52.1% in Taiwan, and 49.6% in China), and for both lymphoid malignancies (52.5%, 50.5%, and 38.3%) and myeloid malignancies (45.9%, 33.4%, and 24.8%). For children diagnosed during 2010-14, 5-year survival for acute lymphoblastic leukaemia ranged from 49.8% in Ecuador to 95.2% in Finland. 5-year survival from brain tumours in children is higher than for adults but the global range is very wide (from 28.9% in Brazil to nearly 80% in Sweden and Denmark). INTERPRETATION: The CONCORD programme enables timely comparisons of the overall effectiveness of health systems in providing care for 18 cancers that collectively represent 75% of all cancers diagnosed worldwide every year. It contributes to the evidence base for global policy on cancer control. Since 2017, the Organisation for Economic Co-operation and Development has used findings from the CONCORD programme as the official benchmark of cancer survival, among their indicators of the quality of health care in 48 countries worldwide. Governments must recognise population-based cancer registries as key policy tools that can be used to evaluate both the impact of cancer prevention strategies and the effectiveness of health systems for all patients diagnosed with cancer. FUNDING: American Cancer Society; Centers for Disease Control and Prevention; Swiss Re; Swiss Cancer Research foundation; Swiss Cancer League; Institut National du Cancer; La Ligue Contre le Cancer; Rossy Family Foundation; US National Cancer Institute; and the Susan G Komen Foundation
    corecore